The $15 billion ad-powered AI startup your doctor may already be using
OpenEvidence is booming despite questions about accuracy and ads.
Tech news from the best sources
OpenEvidence is booming despite questions about accuracy and ads.
Hospitals report more parents are declining vitamin K shots for their newborns.